Allianz Asset Management Gmb H Global Blood Therapeutics, Inc. Transaction History

Allianz Asset Management Gmb H

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$32.4 - $68.18 $13 Million - $27.4 Million	401,197 New	401,197 $27.3 Million
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $546,263 - $925,238	-14,509 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $337,400 - $476,363	-6,395 Reduced 30.59%	14,509 $800,000
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $404,215 - $678,696	-8,295 Reduced 28.41%	20,904 $1.32 Million
Q1 2020 May 14, 2020	BUY	$41.72 - $87.2 $117,233 - $245,032	2,810 Added 10.65%	29,199 $1.49 Million
Q4 2019 Feb 13, 2020	BUY	$45.7 - $81.86 $818,258 - $1.47 Million	17,905 Added 211.04%	26,389 $2.1 Million
Q3 2019 Nov 13, 2019	SELL	$45.35 - $57.91 $930,400 - $1.19 Million	-20,516 Reduced 70.74%	8,484 $412,000
Q2 2019 Aug 08, 2019	BUY	$52.6 - $63.29 $1.01 Million - $1.21 Million	19,183 Added 195.41%	29,000 $1.53 Million
Q1 2019 May 13, 2019	SELL	$39.99 - $53.48 $1.13 Million - $1.51 Million	-28,312 Reduced 74.25%	9,817 $520,000
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $139,186 - $205,954	-4,413 Reduced 10.37%	38,129 $1.55 Million
Q3 2018 Nov 13, 2018	SELL	$38.0 - $51.1 $176,358 - $237,155	-4,641 Reduced 9.84%	42,542 $1.62 Million
Q2 2018 Aug 13, 2018	BUY	$38.7 - $50.15 $331,968 - $430,186	8,578 Added 22.22%	47,183 $2.13 Million
Q1 2018 May 14, 2018	SELL	$39.6 - $65.9 $385,308 - $641,207	-9,730 Reduced 20.13%	38,605 $1.87 Million
Q4 2017 Feb 13, 2018	BUY	$29.7 - $45.7 $1.44 Million - $2.21 Million	48,335	48,335 $1.9 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.